Study Group: Physicians who Perform Procedures using the Da Vinci Robotic Surgical System
Council Members in this Study Group: 229
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
- Samir Mehta
Orthopaedic Surgeon
Hospital of the University of Pennsylvania - CC
Samir Mehta, MD, is an orthopaedic surgeon at the Hospital of the University of Pennsylvania. Previously, he was an Instructor at Harborview Medical Center and Orthopaedic Surgeon and Assistant Professor of Orthopaedic Surgery in the Division of Orthopaedic...
Paul CorsiPartner and Obstetrician Gynecologist
Associated Obstetrics and GynecologyPaul Corsi, MD, is a board-certified Obstetrician Gynecologist at Associated Obstetrics and Gynecology in Michigan. His interests include gynecological surgical operations, infertility, and treatment of many gynecological problems, including endometriosis...
Keith AllenDirector, Cardiothoracic Vascular Surgery Research
Mid America Heart & Lung Surgeons, PCKeith Allen, MD, is a Director of Cardiothoracic-Vascular Surgery Research at the Mid America Heart Institute in Kansas City, Missouri. He is board certified in Thoracic, Vascular, and General Surgery. Dr. Allen maintains an active clinical research department...
Ravi MunverVice Chairman, Chief of Minimally Invasive Surgery
HACKENSACK UNIVERSITY MEDICAL CENTERRavi Munver, MD, is the Vice Chairman and Chief of Minimally Invasive and Robotic Urologic Surgery at Hackensack University Medical Center, New Jersey. He is an Associate Professor of Urology and is a Faculty at Touro University College of Medicine and...
- Peter Davis
President and Chief Executive Officer
ST JOSEPH HOSPITALPeter Davis, MPH, MHA, FACHE, is the President and Chief Executive Officer at the St. Joseph Hospital and Trauma Center in Nashua, which is a part of the St. Joseph Hospital System in New Hampshire. He has over 35 years of experience in hospital administration,...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Prostate Cancer Genetic Testing - Is it real or is it boutique lab work?
January 20, 2009
Analysis by: Mitchell Bamberger, Attending Physician,Clarient Launches Gene Expression Test for Prostate Cancer | www.medcompare.com
Genetic testing for clinically significant prostate cancer is vital to allow clinicians to treat patients. This appears to be a step in the right direction, although it does not seem this will have a major impact for the majority of cases. The study represents only a small subgroup of patients that may have some benefit from this new molecular biology test.
-
Intermittent hormonal therapy for Prostate Cancer: Is it here yet?
January 2, 2009
Analysis by: Mitchell Bamberger, Attending Physician,Finnish Multicenter Study Comparing Intermittent To Continuous Androgen Deprivation For Advanced Prostate Cancer | www.medicalnewstoday.com
prostate cancer, hormonal therapy, intermittent treatemtent
-
Prostate cancer DNA vaccine trial - a necessary step
December 29, 2008
Analysis by: Mitchell Bamberger, Attending Physician,Approval From The Swedish Medical Products Agency To Start A Clinical Trial Using A Xenogenic PSA DNA Vaccine | www.medicalnewstoday.com
prostate cancer, vaccine, dna
-
Robotic Prostatectomy ?Too soon to tell?
May 29, 2008
Analysis by: Mitchell Bamberger, Attending Physician,Mixed Outcomes in Laparoscopy for Prostates | www.nytimes.com
The data gives a mixed review regarding the robotic assisted radical prostatectomy for prostate cancer. There is a clear advantage in regards to a significantly decreased risk of bleeding, post operative pain, and earlier return to normal activities. However, the data does not show a clinical advantage in cancer cure or clinically significant improvement in cancer control. Much more data is needed over a longer period of time. The article does not mention surgeon experience, i.e. those who have done many robotic prostatectomies vs. a surgeon with a limited experience. Nor does the article mention post operative complications such as preservation of erectile function and continence control.
-
A new drug that would change the way we treat Atrial Fibrillation!
May 20, 2008
Landmark ATHENA Study findings with dronedarone presented during the annual Heart Rhythm meeting in San Francisco | www.medscape.com
Atrial fibrillation management. New anti-arrhythmic medication.
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Physician - Director
- Physician - Division Head
- Partner
- Physician - Department Chair
- Director
- Owner
- President
Related Study Groups
GLG Live Meetings with this Study Group's Leading Experts (?)
March 19, 2008 | Boston
GLGi: OrthopedicsJuly 11, 2006 | New York
GLGi: Robotic Surgery in UrologyGLG Webcasts & Teleconferences
Leading Experts in Physicians who Perform Procedures using the Da Vinci Robotic Surgical System have not participated in any GLG webcasts.